Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2014 · 10-Q
Revenue$4.94M$4.94M+2.2% vs Q3 2013 Net Income$236.57K$236.57K+21.7% vs Q3 2013 EPS Diluted$0.02$0.02±0.0% vs Q3 2013 Operating Income$428,958−26.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$930,033N/M Margins · derivedOperating margin8.7%−3.4 pt vs Q3 2013
Net margin4.8%+0.8 pt vs Q3 2013
ended Aug 31, 2014 · filed Oct 15, 2014 · 45 d after period end